Association of PD‐L1 expression status with the efficacy of PD‐1/PD‐L1 inhibitors and overall survival in solid tumours: A systematic review and meta‐analysis
Liu, Xi, Guo, Chang‐Ying, Tou, Fang‐Fang, Wen, Xiao‐Ming, Kuang, Yu‐Kang, Zhu, Qian, Hu, Hao
Published in International journal of cancer (01.07.2020)
Published in International journal of cancer (01.07.2020)
Get full text
Journal Article
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma
Guo, Chang-Ying, Zhu, Qian, Tou, Fang-Fang, Wen, Xiao-Ming, Kuang, Yu-Kang, Hu, Hao
Published in BMC cancer (29.03.2019)
Published in BMC cancer (29.03.2019)
Get full text
Journal Article
microRNA‐1321 and microRNA‐7515 contribute to the progression of non‐small cell lung cancer by targeting CDC20
Hu, Hao, Tou, Fang‐Fang, Mao, Wei‐Min, Xu, Yan‐Liang, Jin, Hui, Kuang, Yu‐Kang, Han, Chun‐Bin, Guo, Chang‐Ying
Published in The Kaohsiung journal of medical sciences (01.05.2022)
Published in The Kaohsiung journal of medical sciences (01.05.2022)
Get full text
Journal Article
The relative and absolute benefit of programmed death receptor-1 vs programmed death ligand 1 therapy in advanced non-small-cell lung cancer: A systematic review and meta-analysis
Yi, Kun, Zhu, Qian, Kuang, Yu-Kang, Jiang, Si-Cong, Hu, Hao
Published in International immunopharmacology (01.10.2020)
Published in International immunopharmacology (01.10.2020)
Get full text
Journal Article
Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells
Guo, Chang-Ying, Yan, Chen, Luo, Lan, Goto, Shinji, Urata, Yoshishige, Xu, Jian-Jun, Wen, Xiao-Ming, Kuang, Yu-Kang, Tou, Fang-Fang, Li, Tao-Sheng
Published in Oncology reports (01.04.2017)
Published in Oncology reports (01.04.2017)
Get full text
Journal Article
Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK -positive NSCLC
Zhu, Qian, Hu, Hao, Jiang, Feng, Guo, Chang Ying, Yang, Xiong Wen, Liu, Xi, Kuang, Yu Kang
Published in Oncotarget (26.09.2017)
Published in Oncotarget (26.09.2017)
Get full text
Journal Article
Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis
Hu, Hao, Qing Lin, Wei, Zhu, Qian, Wen Yang, Xiong, Wang, Hai Dong, Kuang, Yu Kang
Published in Oncotarget (06.12.2016)
Published in Oncotarget (06.12.2016)
Get full text
Journal Article